Trademarks = 2

Forward Citations = 119

Loading Chart...

1 inventor (with patents filed for the assignee):

David W Osborne (6 out of 41 patents)

6 patents: Sort by Forward Citations

1. 10940142 - Inhibition of crystal growth of roflumilast (2021-03-09),

2. 10172841 - Inhibition of crystal growth of roflumilast (2019-01-08),

3. 10105354 - Inhibition of crystal growth of roflumilast (2018-10-23),

4. 9907788 - Inhibition of crystal growth of roflumilast (2018-03-06),

5. 9895359 - Inhibition of crystal growth of roflumilast (2018-02-20),

6. 9884050 - Inhibition of crystal growth of roflumilast (2018-02-06),

Arcutis, Inc. is a biopharmaceutical company focused on developing innovative therapies for dermatological conditions. With a pipeline of potential treatments for psoriasis, eczema, and other skin diseases, Arcutis is committed to improving the lives of patients with chronic skin conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#173 in Menlo Park, CA

#10,286 in California

#43,751 in US

Menlo Park, CA, United States of America

Arcutis, Inc.

Forward Citations = 119

1 inventor:

David W Osborne (6 out of 41 patents)

Please report any incorrect information to support@idiyas.com